28 May 2021 - BC Cancer, CPHIN and Roche Canada will co-create an evidence-generating framework to leverage real-world data and facilitate cost-effective access to targeted treatments for cancer patients.
Roche Canada is pleased to announce a joint initiative with BC Cancer and the Canadian Personalised Healthcare Innovation Network (CPHIN) to co-create a real-world evidence framework in British Columbia known as the PRecision Oncology Evidence Development in Cancer Treatment (PREDiCT).
The PREDiCT initiative will generate and assess real world evidence, which may be used to help shape new sustainable reimbursement pathways for personalised cancer treatments.